Probiotics in Surgery

• Authors: Marcin Folwarski , Marek Dobosz
• Languages of publication: EN

Abstracts

EN

• Publisher: Index Copernicus International
• Journal: Polish Journal of Surgery
• Year: 2010
• Volume: 82
• Issue: 8
• Pages: 489-495

Dates

published

1 - 8 - 2010

online

22 - 9 - 2010

Contributors

author

Marcin Folwarski

• Department of General and Gastroenterological Surgery and Clinical Nutrition, M. Kopernik Pomeranian Traumatology Center, Gdańsk

author

Marek Dobosz

• Department of General and Gastroenterological Surgery and Clinical Nutrition, M. Kopernik Pomeranian Traumatology Center, Gdańsk

References

• Metchnikoff E: The prolongation of life. New York: G. P. Putnom & Sons. 1907.
• FAO/WHO Working Group: Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May 1, 2002.
• Walker WA, Goulet O, Morelli L et al.: Progress in the science of probiotics: from cellular microbiology and applied immunology to clinical nutrition. Eur J Nutr 2006; 45 Supl. 9: 1-18.
• Szajewska H: Probiotyki, historia, definicja, mechanizm działania.
• Sarem-Damerdji LO, Sarem F, Marchal L et al.: In vitro colonization ability of human colon mucosa by exogenous Lactobacillus strains. FESM Microbiol Lett 1995; 131: 133-37.
• Silva M, Jacobus NV, Deneke C et al.: Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987; 31: 1231-33.
• Huttunen E, Noro K, Yang Z: Purification and identification of antimicrobial substances produced by two Lactobacillus casei strains. International Dairy Journal 1995; 5(5): 503-13.[Crossref]
• Savadogo A, Ouattara et al.: Bacteriocins and lactic acid bacteria - a minireview. African Journal of Biotechnology 2006; 5(9): 678-83.
• Wilson KH, Perini I: Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988; 56: 2610-14.[PubMed]
• Vandenbergh PA: Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 1993; 12: 221-38.[Crossref]
• De Simone C, Ciardi A, Gtassi A et al.: Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunophamacol Immunotoxicol 1992; 14: 331-40.[Crossref]
• Perdigon G, De Macias MEN, Alvarez S et al.: Effect of perorally administered Lactobacilli on macrophage activation in mice. Infect Immun 1986; 53: 404-10.
• Carol M, Borruel N, Antolin M et al.: Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn''s disease. J Leukoc Biol 2006; 79: 917-22.[Crossref]
• Rigby RJ, Knight SC, Kamm MA et al.: Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol 2005; 139(2): 245-56.
• Mack DR, Michail S, Wei S et al.: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: G941-50 38. Sperti GS. Probiotics. West Point, CT: Avi Publishing.
• Mattar AF, Daniel H. Teitelbaum RA et al.: Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 2002; 18: 586-90.
• Balzan S, de Almeida Quadros C, de Cleva R et al.: Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol 2007; 22(4): 464-71.[WoS][Crossref]
• Wang M, Adawi D, Molin G et al.: Identification of the translocating bacteria in rats with acute liver injury and their relation to the bacterial flora of the intestinal mucosa. APMIS 2001; 109: 551-58.[Crossref]
• McNaught CE, Woodcock NP, MacFie J et al.: A prospective randomized study of the probiotic Lactobacillus plantarum 299v on indices of gut barrier function in elective surgical patients. Gut 2002; 51: 827-31.
• Guarner F, Khan AG, Garisch J et al.: World Gastroenterology Organization Practice Guideline: Probiotics and Prebiotics-May 2008. South African Gastroenterology Review Sabinet Online 2008; 6: 22, 14-25.
• Sazawal S, Hiremath G, Dhingra U et al.: Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006; 6: 374-82.[Crossref]
• Hickson M, D'Souza AL, Muthu N et al.: Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335(7610): 80.[WoS]
• Gionchetti P, Rizzello F, Helwig U et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.: Gastroenterology 2003; 124: 1202-09.[Crossref]
• Nikfar S, Rahimi R, Rahimi F et al.: Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum 2009; 52(10): 1805; author reply 1806.
• Nista EC, Candelli M, Cremonini F et al.: Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther 2004; 20: 1181-88.[Crossref]
• Tong JL, Ran ZH, Shen J et al.: Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007; 25: 155-68.
• Rayes N, Seehofer D, Theruvath T et al.: Effect of enteral nutrition and synbiotics on bacterial infection rates after pyloruspreserving pancreatoduodenectomy. Ann Surg 2007; 246: 36-40.[Crossref][WoS]
• Rayes N, Hansen S, Seehofer D et al.: Early enteral supply of fiber and lactobacilli versus conventional nutrition: A controlled in patients with major abdominal surgery. Nutrition 2002; 18: 609-15.[Crossref]
• Rayes N, Seehofer D, Hansen S et al.: Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation 2002; 74: 123-28.[Crossref]
• McNaught CE, Woodcock NP, MacFie J et al.: A prospective randomized study of the probiotic lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 2002; 51: 827-31.
• Anderson ADG, McNaught CE, Jain PK et al.: Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004; 53: 241-24.[Crossref]
• Kanazawa H, Nagino M, Kamiya S et al.: Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbeck's Arch Surg 2005; 390: 104-13.
• Rayes N, Seehofer D, Theruvath T et al.: Supply of pre and probiotics reduces bacterial infection rates after liver transplantation - A randomized, double-blind trial. Am J Transplant 2005; 5: 125-30.[Crossref]
• Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A et al.: Benefits of a synbiotic formula (Synbiotic 2000 forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 2006; 30: 1848-55.
• Sugawara G, Nagino M, Nishio H et al.: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery. Ann Surg 2006; 244: 706-14.
• Nomura T, Tsuchiya Y, Nashimoto A et al.: Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 2007; 54: 661-63.
• Reddy BS, Macfie J, Gatt M et al.: Randomized clinical trial of effect of synbiotics, neomycinand mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 2007; 94: 546-54.[Crossref][WoS]
• Pitsouni E, Alexiou V, Saridakis V et al.: Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2009; 65(6): 561-70. Epub 2009 Mar 27.[WoS][Crossref]
• Olah A, Belagyi T, Poto L et al.: Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double-blind study. Hepato-Gastroenterology 2007; 54: 590-94.
• Besselink MGH, van Santvoort HC, Buskens E et al.: Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 651-59.
• Woodard GA, Encarnacion B, Downey JR et al.: Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg 2009; 13(7): 1198-204. Epub 2009 Apr 18.[Crossref]
• Wattenberg LW: An overview of chemoprevention: current status and future prospects. Proc Soc Exp Biol Med 1997; 216: 133-41.
• Hinnebusch BF, Meng S, Wu JT et al.: The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 2002; 132: 1012-17.[PubMed]
• Klinder A, Gietl E, Hughes R et al.: Gut fermentation products of inulinderived prebiotics beneficially modulate markers of tumour progression in human colon tumour cells. Int J Cancer Prev 2004; 1: 19-32.
• Beatrice L. Pool-Zobel BJ, Sauer J: Overview of Experimental Data on Reduction of Colorectal Cancer Risk by Inulin-Type Fructans. American Society for Nutrition J Nutr 137: 2580S-2584S, November 2007.
• Pool-Zobel BL: Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr 2005; 93: Suppl 1: S73-90.
• Femia AP, Luceri C, Dolara P et al.: Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002; 23: 1953-60.[Crossref]
• Klinder A, Forster A, Caderni G et al.: Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr Cancer 2004; 49: 144-55.[Crossref]
• Książyk J: Probiotyki i prebiotyki w karcynogenezie. Pediatria Współczesna. Gastroenterologia, Hepatologia i Żywienie Dziecka 2002; 4(1): 61-62.
• Van Loo J, Clune Y, Bennett M et al.: The SYN-CAN project: goals, set-up, first results and settings of the human intervention study. Br J Nutr 2005; 93 Suppl 1: S91-98.

Identifiers

DOI

10.2478/v10035-010-0071-4